Back to Search
Start Over
Immunogenicity of Recombinant Maltose-binding Protein (MBP)-Gonadotropin Releasing Hormone I (GnRH-I).
- Source :
-
Systems Biology in Reproductive Medicine . Dec2010, Vol. 56 Issue 6, p478-486. 9p. 1 Color Photograph, 2 Black and White Photographs, 2 Charts, 3 Graphs. - Publication Year :
- 2010
-
Abstract
- A recombinant fusion protein, maltose-binding protein (MBP) - gonadotropin releasing hormone I (GnRH-I), was produced by cloning a gene fragment encoding a tandem repeated GnRH-I hexmer peptide (GnRH-I6) into the pMAL-c4x vector which was subsequently expressed in E. coli TB1. MBP-GnRH-I6 was affinity purified. MBP-GnRH-I6 was verified by SDS-PAGE and Western blot and immunogenicity tested in boars. Injection of the recombinant fusion protein into boars yielded a high-titer antibody specific for GnRH-I. This was followed by serum testosterone and the degeneration of spermatogenesis. These results showed that MBP-GnRH-I6 acted as a strong immunogen and could be a candidate for an immune antifertility vaccine. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 19396368
- Volume :
- 56
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Systems Biology in Reproductive Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 55172465
- Full Text :
- https://doi.org/10.3109/19396368.2010.481005